Related Experiment Video
Updated: Jul 9, 2025

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
Challenges to successful outcomes in AYAs with ALL and potential solutions
Annabelle Anandappa1, Emily Curran1
1Department of Internal Medicine, Section of Hematology/Oncology, University of Cincinnati Cancer Center, Cincinnati, OH.
Insights
Survival outcomes for adolescents and young adults with acute lymphoblastic leukemia (ALL) lag behind pediatric patients. Addressing disease biology, therapy adherence, and clinical trial access is key to improving ALL survival in AYAs.
Area of Science:
- Hematology
- Oncology
- Clinical Research
Background:
- Pediatric acute lymphoblastic leukemia (ALL) survival has improved, but outcomes for adolescents and young adults (AYAs) remain suboptimal.
- AYAs with ALL face unique challenges contributing to inferior survival rates compared to younger pediatric patients.
Purpose of the Study:
- To review the multifactorial reasons for poorer survival in AYAs with ALL.
- To highlight novel therapeutic strategies and supportive care interventions for improving outcomes in this population.
Main Methods:
- Literature review of recent advancements in ALL treatment for AYAs.
- Analysis of challenges including disease biology, therapy adherence, and healthcare system integration.
Main Results:
- AYAs with ALL exhibit more frequent adverse disease biology, necessitating targeted therapies like JAK inhibitors, menin inhibitors, and BCL2/BCLXL inhibitors.
- Technology-based interventions show promise for improving therapy adherence in AYAs.
- Enhanced access to clinical trials and improved collaboration between pediatric and adult centers are crucial.
Conclusions:
- Recognizing and addressing the specific challenges in AYAs with ALL, including disease biology and adherence, is essential for improving survival.
- Continued research and collaborative efforts offer hope for better outcomes in AYAs with ALL.
Abstract:
Despite improvements in survival among pediatric patients with acute lymphoblastic leukemia (ALL), survival outcomes for adolescents and young adults (AYAs) with ALL have lagged. The reasons for the inferior outcomes among AYAs are multifactorial, each presenting unique challenges and requiring novel solutions. First, adverse disease biology is more common among AYAs with ALL. Ongoing trials are investigating novel approaches to treatment, such as incorporating JAK inhibitors for Philadelphia chromosome-like ALL, menin inhibitors for KMT2A-rearranged ALL, and BCL2/BCLXL inhibition for T-cell ALL. Poorer adherence to therapy also impedes improvements in survival outcomes for AYAs with ALL, but early data suggest that technology, both for monitoring and interventions, may be useful in increasing adherence among this population. Finally, better access to clinical trials and collaboration between pediatric and adult centers is critical in advancing the care of AYAs with ALL. Significant improvements have been made over the past decade, but recognizing, understanding, and addressing each of these unique challenges provides hope that the outcomes for AYAs will continue to improve even further.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Behavior Modification
A real-world application of operant conditioning principles is applied...
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
Elements Crucial for Effective Psychotherapy
The Therapeutic Alliance
The therapeutic alliance refers to the relationship between the therapist and the client. The alliance strengthens when the therapist and the client engage in a nurturing, supportive, trusting, empathetic, and respectful relationship, improving therapeutic outcomes. Therapists must monitor this relationship...
Self-Discrepancy Theory
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic...

